The Tumor Associated Calcium Signal Transducer 2 pipeline drugs market research report outlays comprehensive information on the Tumor Associated Calcium Signal Transducer 2 targeted therapeutics, ...
The Cellular Tumor Antigen p53 pipeline drugs market research report outlays comprehensive information on the Cellular Tumor Antigen p53 targeted therapeutics, complete with analysis by indications, ...
The continuous development of novel formulations and delivery methods bolsters its market presence. Segmented by indication, the tumor necrosis factor inhibitor drugs market includes hidradenitis ...
The demonstrated genomic heterogeneity of human cancers is having major impacts on the development and evaluation of cancer therapeutics and molecular diagnostics. Many new cancer drugs target ...
OICR’s Cancer Therapeutics Innovation Pipeline (CTIP) initiative is supporting three research teams with up to $300,000 each to conduct Early Validation projects and another with $300,000 for a Late ...